{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:16:26Z","timestamp":1783458986809,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jare.2026.06.027","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T22:10:18Z","timestamp":1782079818000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic potential of ELABELA in alleviating hereditary hypertrophic cardiomyopathy"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9897-0085","authenticated-orcid":false,"given":"Chao","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jare.2026.06.027_b0005","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","article-title":"Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC state-of-the-art review","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jare.2026.06.027_b0010","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cell.2025.01.011","article-title":"Advances in the study and treatment of genetic cardiomyopathies","volume":"188","author":"Parikh","year":"2025","journal-title":"Cell"},{"issue":"6273","key":"10.1016\/j.jare.2026.06.027_b0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"issue":"10253","key":"10.1016\/j.jare.2026.06.027_b0020","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"issue":"44","key":"10.1016\/j.jare.2026.06.027_b0025","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1093\/eurheartj\/ehad637","article-title":"Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy","volume":"44","author":"Braunwald","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jare.2026.06.027_b0030","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/11.suppl_C.8","article-title":"Abnormal intracellular calcium handling in acute and chronic heart failure: role in systolic and diastolic dysfunction","volume":"11","author":"Perreault","year":"1990","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.jare.2026.06.027_b0035","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1161\/CIRCULATIONAHA.116.025455","article-title":"The role of calcium\/calmodulin-dependent protein kinase II activation in hypertrophic cardiomyopathy","volume":"134","author":"Tardiff","year":"2016","journal-title":"Circulation"},{"issue":"45","key":"10.1016\/j.jare.2026.06.027_b0040","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/eurheartj\/ehz326","article-title":"Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients","volume":"40","author":"Wu","year":"2019","journal-title":"Eur Heart J"},{"issue":"1\u20132","key":"10.1016\/j.jare.2026.06.027_b0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"O'Dowd","year":"1993","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.jare.2026.06.027_b0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/CIRCRESAHA.113.301324","article-title":"Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development","volume":"113","author":"Kang","year":"2013","journal-title":"Circ Res"},{"issue":"6172","key":"10.1016\/j.jare.2026.06.027_b0055","doi-asserted-by":"crossref","DOI":"10.1126\/science.1248636","article-title":"Toddler: an embryonic signal that promotes cell movement via Apelin receptors","volume":"343","author":"Pauli","year":"2014","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jare.2026.06.027_b0060","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","journal-title":"Dev Cell"},{"issue":"1","key":"10.1016\/j.jare.2026.06.027_b0065","first-page":"H124","article-title":"Exacerbated pressor and sympathoexcitatory effects of central Elabela in spontaneously hypertensive rats","volume":"318","author":"Geng","year":"2020","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"10","key":"10.1016\/j.jare.2026.06.027_b0070","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/s41401-022-00875-w","article-title":"Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory, anti-oxidative and anti-proliferative effects","volume":"43","author":"Ye","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"10.1016\/j.jare.2026.06.027_b0075","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.125.324169","article-title":"ELABELA protects against thoracic aortic dissection by maintaining vascular smooth muscle cells homeostasis and regulating NETosis","volume":"46","author":"Zheng","year":"2026","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jare.2026.06.027_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106186","article-title":"Elabela ameliorates doxorubicin-induced cardiotoxicity by promoting autophagic flux through TFEB pathway","volume":"178","author":"Chen","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jare.2026.06.027_b0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.01.020","article-title":"Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6\/STAT3\/GPX4 signaling","volume":"181","author":"Zhang","year":"2022","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.1016\/j.jare.2026.06.027_b0090","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","article-title":"Elabela\/toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension","volume":"135","author":"Yang","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jare.2026.06.027_b0095","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.21037\/jtd-21-1728","article-title":"ELABELA acts as a protective biomarker in patients with atrial fibrillation","volume":"13","author":"Cui","year":"2021","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.jare.2026.06.027_b0100","doi-asserted-by":"crossref","first-page":"11333","DOI":"10.1038\/s41598-024-61480-x","article-title":"Decreased plasma ELABELA level as a novel screening indicator for heart failure: a cohort and observational study","volume":"14","author":"Liu","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jare.2026.06.027_b0105","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12872-021-02197-x","article-title":"Declined ELABELA plasma levels in hypertension patients with atrial fibrillation: a case control study","volume":"21","author":"Ma","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"issue":"30","key":"10.1016\/j.jare.2026.06.027_b0110","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1093\/eurheartj\/ehae421","article-title":"Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice","volume":"45","author":"Lopes","year":"2024","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jare.2026.06.027_b0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-022-02176-5","article-title":"Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice","volume":"29","author":"Chai","year":"2023","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jare.2026.06.027_b0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cvr\/cvae004","article-title":"Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium-glucose cotransporter 2 inhibitors","volume":"120","author":"Wijnker","year":"2024","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10.1016\/j.jare.2026.06.027_b0125","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/s41401-020-00608-x","article-title":"Inhibition of miR-135a-5p attenuates vascular smooth muscle cell proliferation and vascular remodeling in hypertensive rats","volume":"42","author":"Ye","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jare.2026.06.027_b0130","article-title":"Galangin 3-methyl ether alleviates mouse hypertrophic cardiomyopathy via targeting HDAC2 and subsequently inactivating the PI3K-AKT signaling pathway","author":"Zhang","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jare.2026.06.027_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156624","article-title":"Sauchinone preserves cardiac function in doxorubicin-induced cardiomyopathy by inhibiting the NLRP3 inflammasome","volume":"140","author":"Xin","year":"2025","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.jare.2026.06.027_b0140","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","article-title":"A simplified, langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart","volume":"119","author":"Ackers-Johnson","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jare.2026.06.027_b0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ceca.2017.02.003","article-title":"Semi-automated program for analysis of local Ca(2+) spark release with application for classification of heart cell type","volume":"64","author":"Davoodi","year":"2017","journal-title":"Cell Calcium"},{"issue":"11","key":"10.1016\/j.jare.2026.06.027_b0150","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/CS20220226","article-title":"Diminished Rbfox1 increases vascular constriction by dynamically regulating alternative splicing of CaV1.2 calcium channel in hypertension","volume":"136","author":"Song","year":"2022","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.jare.2026.06.027_b0155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13287-017-0651-x","article-title":"Engineering human ventricular heart muscles based on a highly efficient system for purification of human pluripotent stem cell-derived ventricular cardiomyocytes","volume":"8","author":"Li","year":"2017","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"10.1016\/j.jare.2026.06.027_b0160","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jamacardio.2023.2808","article-title":"Cardiac remodeling in subclinical hypertrophic cardiomyopathy: the VANISH randomized clinical trial","volume":"8","author":"Vissing","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.jare.2026.06.027_b0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.jare.2026.06.027_b0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardiores.2004.01.021","article-title":"Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs","volume":"63","author":"Molkentin","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jare.2026.06.027_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.638468","article-title":"Lower plasma elabela levels in hypertensive patients with heart failure predict the occurrence of major adverse cardiac events: a preliminary study","volume":"8","author":"Ma","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.jare.2026.06.027_b0180","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jamacardio.2023.3030","article-title":"Effect of mavacamten on chinese patients with symptomatic obstructive hypertrophic cardiomyopathy: the EXPLORER-CN randomized clinical trial","volume":"8","author":"Tian","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"7","key":"10.1016\/j.jare.2026.06.027_b0185","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1021\/acs.jmedchem.5b01549","article-title":"Discovery and structure-activity relationship of a bioactive fragment of ELABELA that modulates vascular and cardiac functions","volume":"59","author":"Murza","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.jare.2026.06.027_b0190","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2019.04.089","article-title":"Recombinant Fc-Elabela fusion protein has extended plasma half-life andmitigates post-infarct heart dysfunction in rats","volume":"292","author":"Xi","year":"2019","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.jare.2026.06.027_b0195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41587-023-01756-1","article-title":"Efficient engineering of human and mouse primary cells using peptide-assisted genome editing","volume":"42","author":"Zhang","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2026.06.027_b0200","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.2147\/IJN.S467876","article-title":"Albumin nanoparticle-based drug delivery systems","volume":"19","author":"Qu","year":"2024","journal-title":"Int J Nanomed"},{"issue":"1","key":"10.1016\/j.jare.2026.06.027_b0205","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/s41467-025-57481-7","article-title":"AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy models","volume":"16","author":"Greer-Short","year":"2025","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.jare.2026.06.027_b0210","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41591-022-02190-7","article-title":"Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice","volume":"29","author":"Reichart","year":"2023","journal-title":"Nat Med"},{"issue":"23","key":"10.1016\/j.jare.2026.06.027_b0215","article-title":"Leucine-rich repeat-containing G protein-coupled receptor 6 ameliorates pressure overload-induced cardiac hypertrophy by regulating cardiomyocyte metabolic reprogramming","volume":"12","author":"Zhao","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.jare.2026.06.027_b0220","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41574-021-00603-0","article-title":"Highlights from SfE BES 2021","volume":"18","author":"Starling","year":"2022","journal-title":"Nat Rev Endocrinol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226005096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226005096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:43:30Z","timestamp":1783457010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123226005096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"alternative-id":["S2090123226005096"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2026.06.027","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of ELABELA in alleviating hereditary hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2026.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}